Sandra Tong

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with…

The Journal of Rheumatology · 2011 · Last of 9 authors · 106 citations

Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

American Journal of Hematology · 2019 · 102 citations